Product Information
NEURONTIN 800 MG TABLET is a brand product labeled by Viatris Specialty LLC, priced at $16.8814 per EA under NDC 58151028501. Its NADAC has been published 44 times since Dec 3, 2025.
FDA first approved this application on Oct 9, 1998. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the gabapentin market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
800 mg/1
Manufacturer
Viatris Specialty LLCNDC
58151028501
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
GABAPENTINApproval Type
New Drug (NDA)
FDA Application
NDA020882FDA Approved
10/9/1998
TE Code
AB1
On Market Since
9/19/2025
Pharmacological Classes
Price Statistics
The NADAC for NEURONTIN 800 MG TABLET has been published 44 times since Dec 3, 2025, and over the history we have for it it has risen 5.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $16.8814 per EA |
|---|---|
| All-time high | $16.9777 (Sep 16, 2026) |
| All-time low | $16.0811 (Dec 3, 2025) |
| 52-week high | $16.9777 |
| 52-week low | $16.0811 |
| Median price | $16.8851 |
| Average price | $16.8041 |
| Largest weekly change | +5.0% (Jan 7, 2026) |
| Weeks tracked | 44 |
| Tracking since | Dec 3, 2025 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 99% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Viatris Specialty LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
gabapentin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NEURONTIN 800 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for NEURONTIN 800 MG TABLET, manufactured by Viatris Specialty LLC, is $16.8814 per EA (NDC 58151028501), effective Sep 30, 2026.
How has the price of NEURONTIN 800 MG TABLET changed over time?
Over the history we have for it, the NADAC for NEURONTIN 800 MG TABLET has risen 5.0%. It has been tracked across 44 weekly CMS publications since Dec 3, 2025.
What are the highest and lowest recorded NADAC prices for NEURONTIN 800 MG TABLET?
Since Dec 3, 2025, the NADAC for NEURONTIN 800 MG TABLET has ranged from a low of $16.0811 (Dec 3, 2025) to a high of $16.9777 (Sep 16, 2026), with a median of $16.8851 per EA.
Are there cheaper alternatives to NEURONTIN 800 MG TABLET?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, GABAPENTIN 800 MG TABLET, is $0.0883 per EA — about 99% below NEURONTIN 800 MG TABLET.
Who manufactures NEURONTIN 800 MG TABLET?
NEURONTIN 800 MG TABLET (NDC 58151028501) is labeled by Viatris Specialty LLC, and CMS classifies it as a brand product.